Discover Why Ultrapure Water is Critical for HPLC and LC-MS
Article

The Importance of Water Purity when Studying Endocrine Disruptors

Detecting endocrine disrupting compounds for monitoring or characterization requires ultrapure water for consistent results. 

Share

Endocrine disrupting compounds (EDCs) imitate or interfere with hormone activity, resulting in wide ranging health effects. Monitoring EDC levels requires fast, reliable, and highly sensitive techniques such as high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS). However, the presence of EDCs or other impurities in water can seriously affect sensitivity and selectivity.

Download this white paper from ELGA Veolia to discover how ultrapure water can prevent sample contamination and ensure more consistent EDC monitoring via HPLC and LC-MS. 

Sponsored by

  • Elga Logo

Top Image Credit:

iStock

Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD
The Scientist Placeholder Image

Streamlining Microbial Quality Control Testing

MicroQuant™ by ATCC logo

Products

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

waters-logo

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis

Nuclera’s eProtein Discovery

Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development